The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD

Summary

This open-label fMRI study will assess the effects of a single dose of psilocybin on rumination and the neural correlates of rumination in individuals with treatment-resistant major depressive disorder.

Timeline

Start

2022-09-15

Primary completion

2023-06-01

Completion

2023-06-01

Outcome

Outcome not reported

Stopped (Enrollment): “Study was terminated due to difficulty recruiting patients who met inclusion/exclusion criteria. No participants received the intervention.”

Drugs

Indications